JELD-WEN Holding

JELD · NYSE

$1.25−$0.10 (−7.41%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.35

JELD analyst rating

HoldConsensus of 4 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold4
Underperform0
Sell0

12-month price target · 5 analysts

Average $1.97 (+57.8% upside)

Low: $1.82
Now: $1.25
High: $2.10

Upgrades and downgrades

The latest rating actions, newest first

JELD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Aug 5, 2026	Maintains	Neutral	$1.60 → $1.80	46%
Barclays	Aug 5, 2026	Maintains	Equal-Weight	$1.50 → $2.00	52%
Barclays	Jul 14, 2026	Maintains	Equal-Weight	$2.50 → $1.50	52%
Goldman Sachs	Jul 10, 2026	Maintains	Neutral	$1.75 → $1.50	45%
UBS	May 6, 2026	Maintains	Neutral	$3.00 → $1.60	46%
Goldman Sachs	Jan 13, 2026	Maintains	Neutral	$3.75 → $3.25	45%
Jefferies	Dec 15, 2025	Maintains	Hold	$2.25 → $2.60	60%
Barclays	Nov 5, 2025	Maintains	Equal-Weight	$5.00 → $3.00	52%

The case for and against

Updated Oct 23, 2025

Bull case

JELD-WEN Holding Inc is positioned for potential growth due to expectations of improved demand and pricing environments, which could enhance operating leverage and adjusted financial metrics. Despite a reported decline in year-over-year sales to $776 million, recent performance has exceeded modest expectations, indicating resilience in the company's revenue generation. Additionally, key catalysts such as stronger housing starts, increased home improvement spending, and favorable pricing developments in North America and Europe could further drive recovery and profitability.

Bear case

JELD-WEN Holding Inc. is facing significant challenges, evidenced by ongoing sharp declines in organic sales, which are anticipated to persist into the second quarter, contributing to a negative outlook for the company. The company's projected revenues for FY'26 have been revised downward to $3.29 billion, with only modest growth expected in comparison to prior estimates of $3.40 billion. Additionally, the anticipated decline in adjusted EBITDA for FY'25, with a reduction to $145 million from previous expectations of $205 million, highlights meaningful margin compression and struggles with profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.